EU awards $7.8M for kidney transplant biomarker development

04/29/2013 | GenomeWeb Daily News (free registration)

The European Commission is providing 13 research groups in Europe with $7.8 million to create biomarker-based tools for evaluating the health of patients who have undergone kidney transplants. The consortium, also known as BIOMARGIN, will develop noninvasive ways to detect allograft lesions and improve the survival of the kidney and patient over the long term.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ